Literature DB >> 15563314

Biology of the lymphatic marker LYVE-1 and applications in research into lymphatic trafficking and lymphangiogenesis.

David G Jackson1.   

Abstract

The pace of research into the lymphatic system continues to accelerate with the availability of new molecular markers. One such marker, LYVE-1, the lymphatic receptor for the extracellular matrix mucopolysaccharide hyaluronan, has been a key component of many important studies on embryonic and tumour-induced lymphangiogenesis, and continues to be used for the detection and isolation of lymphatic endothelial cells. However, LYVE-1 is interesting in its own right. Being a member of the Link protein family whose only other major hyaluronan receptor is directly involved in leukocyte migration and tumour metastasis, LYVE-1 is already implicated in the trafficking of cells within lymphatic vessels and lymph nodes. The current challenge is to determine the precise roles played by LYVE-1 and other scavenger type receptors in the immune functions of the lymphatics as well as to use LYVE-1 and other markers to investigate the way in which tumours exploit lymphatic vessels for metastasis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15563314     DOI: 10.1111/j.1600-0463.2004.apm11207-0811.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  72 in total

1.  Temporal genomewide expression profiling of DSS colitis reveals novel inflammatory and angiogenesis genes similar to ulcerative colitis.

Authors:  Kai Fang; Megan Bruce; Christopher B Pattillo; Songlin Zhang; Randolph Stone; John Clifford; Christopher G Kevil
Journal:  Physiol Genomics       Date:  2010-10-05       Impact factor: 3.107

Review 2.  The new era of the lymphatic system: no longer secondary to the blood vascular system.

Authors:  Inho Choi; Sunju Lee; Young-Kwon Hong
Journal:  Cold Spring Harb Perspect Med       Date:  2012-04       Impact factor: 6.915

3.  Relations between lymphangiogenesis and the size of pterygium.

Authors:  Lin Liu; Shi-Qi Ling; Qiao-Li Li; Tao Wang; Hui Ye; Jie-Zhen Yang; Xiu-Hua Jia
Journal:  Int J Ophthalmol       Date:  2012-06-18       Impact factor: 1.779

4.  Lymphatic injury and regeneration in cardiac allografts.

Authors:  Thing Rinda Soong; Arvind P Pathak; Hiroshi Asano; Karen Fox-Talbot; William M Baldwin
Journal:  Transplantation       Date:  2010-03-15       Impact factor: 4.939

5.  Curcumin suppresses lymphatic vessel density in an in vivo human gastric cancer model.

Authors:  Wei Da; Jinshui Zhu; Long Wang; Qun Sun
Journal:  Tumour Biol       Date:  2015-02-10

6.  Of mice and men; the translational physiology of a genetic form of lymphoedema.

Authors:  P S Mortimer; J R Levick
Journal:  J Physiol       Date:  2006-05-25       Impact factor: 5.182

7.  Proinflammatory signals and the loss of lymphatic vessel hyaluronan receptor-1 (LYVE-1) in the early pathogenesis of laminin alpha2-deficient skeletal muscle.

Authors:  Katherine E Wardrop; Janice A Dominov
Journal:  J Histochem Cytochem       Date:  2011-02       Impact factor: 2.479

Review 8.  Biomarkers of lymphatic function and disease: state of the art and future directions.

Authors:  Kenta Nakamura; Stanley G Rockson
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

9.  Lack of lymphatic vessel phenotype in LYVE-1/CD44 double knockout mice.

Authors:  Mai X Luong; Joshua Tam; Qingcong Lin; Jeroen Hagendoorn; Kathryn J Moore; Timothy P Padera; Brian Seed; Dai Fukumura; Raju Kucherlapati; Rakesh K Jain
Journal:  J Cell Physiol       Date:  2009-05       Impact factor: 6.384

10.  Differential distribution of blood and lymphatic vessels in the murine cornea.

Authors:  Tatiana Ecoiffier; Don Yuen; Lu Chen
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-12-17       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.